Pharmafile Logo

Female pharma

Bayer symbol

Bayer’s non-hormonal menopause drug elinzanetant shows promise in long-term study

Vasomotor symptoms are reported by up to 80% of women during the menopausal transition

Bayer symbol

Bayer’s non-hormonal menopause drug elinzanetant shows promise in phase 3 studies

Vasomotor symptoms are estimated to affect up to 80% of menopausal women

- PMLiVE

Astellas’ menopause drug granted EC approval to treat vasomotor symptoms

More than half of women aged 40 to 64 years experience symptoms such as hot flashes

- PMLiVE

Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant

Vasomotor symptoms affect up to 80% of menopausal women in the US

- PMLiVE

Unmet Needs and Novel Advances at the 2023 Women’s Health Master Class

On November 8-9, Medscape Education held the 2nd Annual Women’s Health Master Class—Modernizing Women's Health: Elevating Quality Care for Everyday Practice, two days dedicated to bringing the latest advances in...

Medscape Education Global

- PMLiVE

A Passionate Cause: Elevating Women to Reshape Medicine

“We need more outstanding leaders from underrepresented communities, including women and those from different ethnicities”, says Antonella Chadha Santuccione, co-founder and CEO of the nonprofit Women's Brain Project in Zurich,...

Medscape Education Global

Hear from her: Meet your hosts

Every day, women leaders are changing the healthcare landscape for the better. Our Women in Healthcare Leadership Podcast Series features some of the women working to elevate equity, achieve gender...

Medscape Education Global

- PMLiVE

New campaign to help guide conversations around the menopause at work for those working in health communications

This World Menopause Day, fox&cat, the Healthcare Communications Association (HCA) and The Menopause Charity have launched a joint campaign to help guide important conversations around the menopause at work for...

Fox&Cat

Medscape Education: ACOG 2023 Publication

Medscape Education is making a difference! We are wrapping CMV Awareness Month with a look at the impact of CMV education on OB/GYN learners. Take a look as Medscape Senior...

Medscape Education Global

- PMLiVE

Shining a Spotlight on Women’s Health Education Outcomes at ACOG 2023

During the 2023 annual meeting of ACOG, Medscape highlighted the outcomes of CME/CE programs focused on improving clinicians knowledge and achieving better outcomes for patients. The outcomes were shared through...

Medscape Education Global

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links